CNBC's Jim Cramer explains why he thinks Intercept's liver drug is going to be big news, and shares his thoughts on the FDA's approval of Exact Sciences' DNA test for colon cancer.
1 / 1
CNBC Videos
Tue, Aug 12, 2014 9:15 AM EDT